首页 正文

medRxiv : the preprint server for health sciences. 2023 Jul 27:2023.07.24.23293127. doi: 10.1101/2023.07.24.23293127

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock

VA-ECMO与Impella联合支持治疗心脏源性休克 翻译改进

Shan P Modi  1, Yeahwa Hong  2, McKenzie M Sicke  3, Nicholas R Hess  4, Wyatt J Klass  5, Luke A Ziegler  5, Ryan M Rivosecchi  6, Gavin W Hickey  7, David J Kaczorowski  4, Raj Ramanan  1

作者单位 +展开

作者单位

  • 1 Department of Critical Care Medicine, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 2 Department of Surgery, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 3 School of Medicine, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 4 Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 5 Heart and Vascular Institute, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 6 Department of Pharmacy, University of Pittsburgh Medical Center Pittsburgh, PA.
  • 7 Division of Cardiology, University of Pittsburgh Medical Center Pittsburgh, PA.
  • DOI: 10.1101/2023.07.24.23293127 PMID: 37546750

    摘要 Ai翻译

    Background: VA-ECMO with concomitant Impella support (ECpella) is an emerging treatment modality for cardiogenic shock (CS). Survival outcomes by CS etiology with ECpella support have not been well-described. Methods: This study was a retrospective, single-center analysis of patients with cardiogenic shock due to acute myocardial infarction ... ...点击完成人机验证后继续浏览
    Copyright © medRxiv : the preprint server for health sciences. 中文内容为AI机器翻译,仅供参考!

    相关内容

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock